Merck discontinues Phase 3 trial for lung cancer combo drug
When compared to patients in the control arm, patients in the vibostolimab and pembrolizumab fixed-dose combination arm…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pembrolizumab
Early research suggests Merck cancer drug may target dormant HIV
Antiretroviral treatments now allow many HIV patients to lead normal lives, but the drugs do not completely remove the virus from…
US FDA approves KEYTRUDA from Merck for adults with relapsed or refractory cHL
KEYTRUDA is the first anti-PD-1 therapy approved for adult patients with relapsed or refractory cHL after frontline therapy